Search Results 241-250 of 16337 for immunothérapie Bylaska

  1. Ipilimumab (intravenous route) - Mayo Clinic

    Ipilimumab injection is used in combination with other medicines (eg, nivolumab) as first-line treatment to treat patients with kidney cancer that has spread ...

  2. Medical Research & Education - Mayo Clinic News Network

    Protein may Predict Response to Immunotherapy in Patients with Metastatic Melanoma featured image. Cancer. Protein may Predict Response to Immunotherapy in ...

  3. Vorinostat, Temozolomide, or Bevacizumab in Combination with Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients with Newly Diagnosed High-Grade Glioma - Mayo Clinic

    Must not have received any prior chemotherapy, radiotherapy, immunotherapy, or bone marrow transplant; More than 7 days since major surgical procedure and ...

  4. Venetoclax (oral route) - Side effects & dosage - Mayo Clinic

    Venetoclax is used alone or together with other medicines (eg, rituximab) to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with ...

  5. Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Relapsed/Refractory Large B-cell Lymphoma - Mayo Clinic

    Use of any standard or experimental anti-cancer therapy within 2 weeks prior to enrollment, including cytoreductive therapy and radiotherapy, immunotherapy, or ...

  6. Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) - Mayo Clinic

    Combination immunotherapy with lenalidomide and rituximab is an immunomodulatory regimen that has shown promising activity in patients with indolent B-cell ...

  7. Clinical trials - Oncology (Medical)

    The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell malignancies ...

  8. Mayo Clinic Minute: Why people with breast cancer should ask their health care team about clinical trials

    "Enrolling these patients into the clinical trial, first of all, they actually might benefit from these novel treatments, like immunotherapy," says Dr.

  9. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    Immunotherapy with obinutuzumab, may induce changes in body's immune system and may interfere with the ability of cancer cells to grow and spread. Drugs ...

  10. Clinical trials - Oncology (Medical)

    ... immunotherapy, or chemoimmunotherapy. Brain Tumor Repository. Scottsdale/Phoenix, Ariz. The main objective of the Brain Tumor Repository is to allow access ...